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ABSTRACT
Our approach to cartilage tissue-engineering scaffolds combines image-based design and solid free-
form (SFF) fabrication to create load-bearing constructs with user-defined parameters. In this study, 3-
dimensional scaffolds with cubic and ellipsoidal pore architecture were fabricated using poly(propylene
fumarate) (PPF). To increase seeding efficiency and cellular retention, hydrogels were used to deliver cells
into the scaffolds. The first objective of this studywas to evaluate the concentrations of composite hyaluronic
acid (HyA) and collagen I hydrogels best able to stimulate proteoglycan synthesis in porcine chondrocytes in
vitro and in vivo. The second objective was to evaluate the differences in extracellularmatrix production due
to pore geometry and scaffold design. For the in vitro assessment, chondrocytes were encapsulated in col-
lagen I hydrogels with varying concentrations of HyA. Hydrogels were cultured for 1 and 2 weeks, and then
the sulfated glycosaminoglycan (sGAG) content was quantified using a dimethyl-methylene blue assay. The
concentration of HyAbest able to increase ECM synthesis was 5%HyA/collagen I, or 0.23mg/mLHyA. The
results from the in vitro experiment were used as culture parameters for the in vivo analysis. Composite 5%
HyA/collagen I or collagen I–only hydrogels were used to seed chondrocytes into SFF-fabricated scaffolds
made of PPF with designed cubic or ellipsoidal pore geometry. The scaffolds were implanted subcutane-
ously in immunocompromised mice for 4 weeks. Histomorphometric analyses of sections stained with Saf-
ranin O were used to quantify the amount of ECM deposited by cells in the scaffolds. Scaffolds seeded with
5% HyA/collagen hydrogels had significantly greater areas of positive Safranin O staining (approximately
60%, compared with 30% for scaffolds with collagen I hydrogels only), indicating that greater numbers of
chondrocytes retained their metabolic activity in the ectopic environment. These scaffolds also had greater
stain intensities (corresponding to greater amounts of sGAG in the ECM) than their counterparts seeded
with collagen I hydrogels alone. Significant differences in matrix production were not found between the
scaffold pore designs. Overall, these results indicate that a combination of composite HyA hydrogels and
designed SFF scaffolds could provide a functional tissue-engineered construct for cartilage repair with
enhanced tissue regeneration in a load-bearing scaffold.
INTRODUCTION
ARTICULAR CARTILAGE LESIONS have poor regenerativecapacity. Tissue engineering provides new methods
of combining cells, matrices, and biological factors, poten-
tially facilitating the regeneration of cartilage tissue after
injury. Hydrogels and porous scaffolds implanted at de-
fect sites increase the retention of cells and provide a 3-
dimensional matrix within which the cells can differentiate.
Growth factors and other biologics can also be delivered
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using these matrices, to further improve the characteristics
of the repair tissue. Although many studies have shown that
scaffolds can support chondrogenesis, the regeneration of
viable, fully functional cartilage capable of supporting loads
is yet to be achieved.
Collagen is an ideal substrate for cartilage tissue engi-
neering because it can be formed in situ, is easily manipu-
lated, and can serve as a natural, biologic delivery vehicle
for cells and growth factors. Collagen hydrogels have been
explored in numerous applications, including regeneration
of vocal chords1 and repair of spinal cord conduits2 and
cartilage defects.3,4 However, collagen I fibrils have been
shown to destabilize the phenotype of chondrocytes, ac-
quiring fibroblast-like morphologies and producing colla-
gen I and collagen X instead of collagens II, IX, and XI.5,6
Chondrocytes cultured in collagen I gels hence exhibit less
proliferation and biosynthetic activity.7,8
The addition of hyaluronic acid (HyA) to collagen I hy-
drogels may help stabilize chondrocyte phenotype and in-
crease proteoglycan synthesis, presenting a possible solution
to mitigate the effect of collagen I fibrils. HyA acid is a ubiq-
uitous proteoglycan found in many tissues of the body. HyA
is required for maintenance of the pericellular matrix and
lubrication of the joint surface and is partially responsible
for the characteristic ability of cartilage to withstand com-
pression due to its organization and retention of aggrecan and
sulfated glycosaminoglycans (sGAGs) within the extracellu-
lar matrix. Chondrocytes bind to HyA through cell surface
receptors, which initiate signals that modulate cell prolifera-
tion, migration, and differentiation.9,10 The benefits of HyA
in facilitating chondrogenesis have been shown in several
studies. Bovine chondrocytes cultured in gelatin sponges
with exogenous high-molecular-weight HyA increase cell
retention and proteoglycan synthesis.11 Chondrocytes embed-
ded in collagen I hydrogels cultured with exogenous HyA in-
crease cell proliferation and chondroitin sulfate synthesis
at 0.1 and 1mg/mL concentrations.12 Furthermore, chondro-
cytes cultured in composite HyA/alginate beads also have
higher sGAG deposition and greater synthesis of deoxyribo-
nucleic acid (DNA) and hydroxyproline.13
Hydrogels, however, inherently have weak mechanical
properties and are incapable of withstanding forces nor-
mally exerted at clinically relevant defect sites. Scaffolds
used to provide structural support may also direct cell growth
and tissue regeneration when parameters such as scaffold
pore size, porosity, and surface area are taken into consider-
ation. Image-based design14 and solid free-form (SFF) fab-
rication methods enable the creation of custom scaffolds with
user-defined characteristics that have complex internal ar-
chitectures and external geometries that are capable of mim-
icking the irregular surfaces of a defect.15 In this study,
scaffolds with cubic or ellipsoidal pore architecture were
used to compare differences in tissue growth due to changes
in the ratio of surface area to volume. A large surface area
encourages cell attachment and growth, whereas a large vol-
ume allows greater seeding density to facilitate tissue de-
velopment.16 The ellipsoid pores should encourage cell-
substrate interactions and stimulate ECM production by in-
creasing cell density in the scaffold pores.
For this study, porous poly(propylene fumarate) (PPF)
scaffolds with the designed architectures described above
were created using indirect SFF methods.17 PPF is a biode-
gradable, biocompatible polymer that has been used previ-
ously for orthopedic applications.18,19 PPF is an unsaturated
linear polyester that can be cross-linked through its fumarate
double bonds using N-vinyl pyrrolidone (NVP). The cross-
linking reaction is propagated using free-radical polymeriza-
tion using benzoyl peroxide and N, N dimethyl-p-toluidine.
The result is an injectable polymer that is moldable to fill
irregularly shaped defects.20 When used in combination
with SFF fabrication methods, 3-dimensional PPF matrices
with defined pores and pore interconnections can be fabri-
cated that are capable of supporting load. These scaffolds
will provide a mechanically protective environment for the
hydrogels and allow nutrient diffusion to support the devel-
oping tissue.
In this study, we evaluated the effects of HyA on chon-
drocyte behavior using a combination of composite HyA/
collagen I hydrogels and designed porous PPF scaffolds.
Our hypothesis was that addition of low concentrations of
high-molecular-weight HyA to collagen I hydrogels would
have a beneficial effect on matrix production and pheno-
type stability. In an in vitro phase of this study, we evaluated
the metabolism and proteoglycan synthesis of chondrocytes
embedded in composite HyA/collagen I hydrogels to deter-
mine HyA concentrations with the greatest benefit (Fig. 1).
In a separate in vivo phase, composite hydrogels were used
in combination with designed scaffolds and implanted in
mice to evaluate the effects of the hydrogels and of scaffold
pore geometry on cell function and ECM production. The
cubic and ellipsoidal pore geometry was investigated to de-
termine whether the differences in surface area:volume ra-
tio and the permeability of the 2 scaffold designs would
affect the metabolic activity of the cells.
MATERIALS AND METHODS
Cell isolation
Primary porcine chondrocytes were isolated from the
metacarpophalangeal joints of domestic pigs. Cartilage
slices were extracted aseptically within 4 h of slaughter.
Chondrocytes were isolated from the tissue using a solu-
tion of 1mg/mL collagenase II (Sigma, St. Louis, MO) in
Dulbecco’s modified Eagle medium (DMEM) containing
500U/mL penicillin and 500 mg/mL streptomycin (P/S),
100U/mL kanamycin, and 1:500 amphotericin B (Fungi-
zone, Gibco, Carlsbad, CA). The tissue was digested for
6 h at 378C with gentle agitation. The cell suspension was
filtered through a nylon sieve (70-mm pore size) and centri-
fuged at 700g for 8min. The pelleted cells were resus-
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pended in basal culture medium (DMEM, 10% fetal bovine
serum (FBS), 1% P/S, Gibco) supplemented with 50 mg/mL
2-phospho-L-ascorbic acid (Sigma) and plated onto tissue
culture flasks. Cells were allowed to adhere for 24 h and
were then trypsinized and used for experimentation.
In vitro experimentation
In vitro cell culture. Cells were encapsulated in collagen
I or composite HyA/collagen I gels and suspended in basal
or chondrogenic media to determine the combination most
favorable for chondrogenesis. After trypsinization, cells
were resuspended at 3.5106 cells/mL in 2mL of collagen
I (stock concentration: 4.66mg/mL; BD Bioscience Dis-
covery Labs, San Jose, CA) with 200 mL of culture medium.
The pH of the collagen/cell suspension was increased with
the addition of 20 mL of 0.5M sodium hydroxide with
220mg/mL sodium bicarbonate. The mixture was pipetted
in 70-mL aliquots into 96-well tissue culture plates. The
resulting collagen I hydrogels were 2.2mm in height
and 6.35mm in diameter. To create the composite HyA/
collagen I gels, HyA (stock concentration: 2.7mg/mL in
0.8M sodium chloride (NaCl), molecular weight 3106
Da; Hyalogic LLC, Edwardsville, KS) was added to the
collagen I cell suspension to produce 1%, 2%, 5%, and
10% (w/w) HyA/collagen I gels. The HyA concentrations
for the corresponding weight percentage gels were 0.05,
0.09, 0.23, and 0.47mg/mL, respectively. The pH was
raised to physiologic levels using sodium hydroxide as
described above. (The amount of collagen I used to re-
suspend the cells in composite hydrogels was adjusted so
that the final volumes of the HyA/collagen cell suspension
FIG. 1. Schematic of experimental design used for this study. Two research stages (in vitro and in vivo experimentation) were used to
evaluate the effect of hyaluronic acid (HyA) on chondrocyte proteoglycan synthesis. In vitro experiments were designed to determine
HyA compositions best able to stimulate sulfated glycosaminoglycan (sGAG) deposition in basal or chondrogenic medium. The results
of the in vitro experimentation were used as culture parameters for in vivo experiments. The hydrogels were evaluated in solid free-form
designed scaffolds with cubic- or ellipsoidal-pored scaffolds to determine whether pore geometry had an effect on sGAG deposition.
DMMB, dimethyl-methylene blue; H&E, hematoxylin and eosin.
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was similar to collagen I only hydrogels.) All hydrogels
were placed in an incubator at 378C and allowed to solid-
ify for 30min. Basal medium or chondrogenic medium
(basal medium supplemented with 50 mg/mL 2-phospho-L-
ascorbic acid, 0.4mM proline (Sigma), 5 mg/mL insulin
(Gibco), and 0.1mM non-essential amino acids (Gibco))
was then added to the tissue culture wells. Chondrocytes
were cultured for up to 2 weeks under gentle agitation on
an orbital shaker and with the media replaced every other
day. Hydrogels was assessed at 1 week and 2 weeks for
GAG content, cell viability, and cell number. Three repli-
cates of each sample were used for each analysis.
Dimethyl-methylene blue assay for GAG quantification.
Cultured hydrogels were rinsed with Hank’s Balanced Salt
Solution (HBSS, Gibco) and then digested with 75 mg/mL
proteinase K in 100mM sodium acetate buffer at 658C for
2 h. After the gels were completely digested, the tempera-
ture was increased to 958C for 10min to inactivate the en-
zyme. The digested samples were centrifuged for 10min at
14,000 rpm and the supernatant kept. Dimethyl-methylene
blue (DMMB) assay was conducted as described by Farn-
dale.21 Briefly, 16mg of DMMB dye was dissolved in 1 L
of water with 3.04 g glycine, 2.37 g NaCl, and 95mL 0.1M
HCl. Five mL of supernatant from each sample was mixed
with 200 mL of DMMB solution, and 525 nm absorbance
was read in a spectrophotometer. Chondroitin sulphate from
shark cartilage (Sigma) was used to create a calibration
curve to correlate the measured absorbance to known
amounts of sGAG. Data from the DMMB analyses were
assessed using the Student t-test with a¼ 0.05. The data
of the groups were compared using analysis of variance
(ANOVA) using hydrogel composition and culture medium
as the factors for the Tukey post hoc test.
Cell viability and count. Cell viability and count were
determined using the Cell Titer 96 AQueous One non-
radioactive cell proliferation assay (Promega, Madison,
WI). Cell viability was determined by reading the 490-nm
absorbance of a formazan product bioreduced from a tet-
razolium compound. Cell count was also determined using
this assay via a linear cell standard correlating the amount
of formazan product formed in a given amount of time
and number of cells present. A hemacytometer and Coulter
counter was used to verify the cell count from digested
hydrogels and validate the cell standard. The amount of
DNA present was calculated from the cell number, assum-
ing 7.7 pg of DNA per cell.
In vivo experimentation
Scaffold design and fabrication. Image-based design
techniques14 were used to create cylindrical scaffolds with
defined internal pore architectures. The external dimensions
of all designed scaffolds were 3mm in height and 5mm in
diameter. Unit cells for cubic and ellipsoidal pore designs
were [0.7mm, 0.7mm, 0.7mm] and [0.7mm, 0.7mm,
0.9mm], respectively (Fig. 2A1, B1). The strut size of the
cubic scaffolds was designed to be 350 mm thick, which
corresponds to pore space dimensions of 350 mm in length,
width, and height. The designed porosity of the scaffold
was 50%. Pore dimensions for ellipsoidal scaffolds were
designed to be 700 mm in diameter and 900 mm in height.
The interconnections between pores for the ellipsoidal scaf-
folds were measured to be 260 mm for the top and bottom
and 300 mm for the sides of the ellipsoid. The designed
porosity for the ellipsoid scaffold was 52%. The unit cells
were then used to create the interconnected pore architec-
ture of the scaffolds shown in Figure 2 (A2, B2).
Wax molds were printed from design files using a 3-
dimensional rapid prototyping system (Patternmaster, So-
lidscape, Inc., Merrimack, NH). The wax molds were cast
into PPF using indirect SFF fabrication techniques de-
scribed previously.22 Briefly, 1 g of PPF (molecular weight
1500 Da) was dissolved in 1mL of NVP. After homoge-
nization, 0.02 g of benzoyl peroxide was added to the PPF/
NVP mixture. Then, 2 mL of N, N-dimethyl-p-toluidine was
added to induce cross-linking immediately before casting.23
A custom polytetrafluoroethylene (PTFE) mold (diameter¼
6mm) was used to force the polymer solution through the
pore spaces of the wax molds. The PTFE mold was placed
in a nitrogen chamber at room temperature for 24 h until the
polymer cured. The wax was then removed with acetone,
and the remaining PPF scaffolds were rinsed in distilled
deionized water and sterilized in 70% ethanol.
Scaffold design verification and permeability calcula-
tions. Scaffolds cast in PPF from the wax molds were
scanned using micro-computed tomography (MS-130, GE
Medical Systems, Toronto, Canada) to determine the accu-
racy of the fabrication process. The scaffolds were scanned
in air at a resolution of 16 mm.
A finite difference technique was used to calculate the









where m is the fluid viscosity and n is the velocity field.
Using standard homogenization theory, the effective
permeability is derived from combining Darcy’s Law (de-
scribing fluid flow at macroscopic level) and the Navier-
Stokes equation, which assumes that the scaffold is a
homogeneous medium with a defined characteristic resis-
tance to the fluid surrounding it.24
In vitro pre-culture. In preparation for cell seeding, the
PPF scaffolds were rinsed twice with sterile HBSS and
once with culture medium. The PPF scaffolds were then
placed in a custom-made PTFE mold (diameter¼ 5.1mm).
Cells were seeded into the scaffold pores using a collagen I
or 5% HyA/collagen I hydrogel similar to those described
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above. For these hydrogels, 40106 cells/mL were resus-
pended in a solution containing *3.8mg/mL collagen I or
5% (w/w) HyA/collagen I after trypsinization. The pH of
the solution was increased, and the cell/hydrogel suspen-
sion was pipetted into the scaffold pores (*60 mL) imme-
diately after sodium hydroxide addition. The gels were
allowed to solidify within the scaffolds in a humidified
chamber at 378C for 30min. The PPF scaffolds were then
removed from the PTFE mold and placed in a 24-well
tissue culture plate. Basal culture medium (DMEM, 10%
FBS, 1% P/S) was added to the wells, and then the plate
was placed in the incubator and gently agitated on an orbital
shaker. The chondrocyte-seeded scaffolds were pre-cultured
for 2 weeks, with the culture medium changed every other
day during this period.
In vivo implantation. After pre-culture, 16 PPF scaffolds
(4 of each combination: cubic or ellipsoidal pore archi-
tecture seeded with collagen I or 5% HyA/collagen I) were
implanted subcutaneously in 5- to 8-week-old immuno-
compromised mice (N:NIH-bg-nu-xid; Charles River,
Wilmington, MA). The animals were anesthetized with
intramuscular injections of ketamine (50 mg/g) and xylazine
(5 mg/g) in saline. Four dorsal subcutaneous pockets were
FIG. 2. Images of scaffolds designed with cubic (A) or ellipsoidal (B) interconnected pore architecture. The external scaffold di-
mensions are 5mm in diameter and 3mm in height. Image-based design files showing the unit cell used for each design. The cubic unit
cell (A1) is [0.7, 0.7, 0.7mm], with designed pore space dimensions: 350350350mm. The ellipsoidal unit cell (B1) is [0.7, 0.7,
0.9mm], with a designed diameter of 700mm and a height of 900mm. Interconnections between ellipsoids are between 260 (top and
bottom) and 300 mm (sides). (A2, B2) View of the xz plane of the designed scaffolds. (A3, B3) Reconstructed micro-computed to-
mography scans of fabricated poly(propylene fumarate) scaffolds. Color images available online at www.liebertpub.com/ten.
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created by blunt dissection, and 1 PPF scaffold from each
experimental group was placed in each pouch and in a
different pouch location in each mouse. The implantation
sites were closed with surgical wound clips. The animals
were housed in groups for 4 weeks with free access to food
and water.
Evaluation of implants. The mice were killed after 4
weeks. The scaffolds were harvested and fixed in Z-FIX
(Anatech, Battle Creek, MI) overnight. The scaffolds were
then dehydrated and processed for histology. The speci-
mens were embedded in paraffin and sectioned at 7 mm.
Sections were affixed to slides and stained with hematoxylin
and eosin (H&E) or Safranin O counterstained with fast
green FCF. Briefly, hydrated slides were immersed for 30 s
in Harris hematoxylin then cleared in running tap water,
followed by 3min in 0.02% fast green FCF, 10 s in 1%
acetic acid, and 6min in 0.1% Safranin O. The slides were
then dehydrated and mounted with Permount (Sigma).
Immunohistochemistry was used to detect collagen I and
collagen II. Paraffin sections were deparaffinized and rehy-
drated. Endogenous peroxidase activity was blocked with
0.3% hydrogen peroxide v/v in methanol. The slides were
rinsed once in distilled water and twice in 0.5M Tris,
0.15M NaCl, pH 7.6 (Tris-buffered saline (TBS)) buffer
for 5min. The slides were then placed in 50mU/mL sheep
hyaluronidase (Sigma) with 1% bovine serum albumin
(BSA, Sigma) solution for 30min at 378C to retrieve the
antigen. The slides were rinsed twice in TBS buffer for
5min, and then 10% (v/v) normal goat serum was used to
block non-specific background staining (1 h at room tem-
perature). All incubations were performed using a humid-
ified chamber. The goat serum was gently shaken off the
slides, and the primary antibody, polyclonal rabbit antisera
raised against human type I collagen or type II collagen
(US Biological, Swampscott, MA) diluted in TBS with 1%
BSA, was placed on the sections for 1 h at room tempera-
ture. The slides were rinsed 3 times in TBS for 5min to
wash away excess primary antibodies. The primary anti-
body was detected using a biotinylated-goat anti-rabbit
secondary antibody and Vectastain ABC reagent according
to the manufacturer’s instructions (Vectastain ABC kit for
rabbit immunoglobulin G, Vector Laboratories, Burlin-
game, CA). Peroxidase activity was visualized using dia-
minobenzidine (DAB substrate kit, Vector Laboratories)
for 5 to 7min. The reaction was stopped by rinsing the
sections with water. The sections were counterstained using
0.02% fast green FCF, dehydrated, and mounted using
Permount. Paraffin slides of a mouse joint were used as
positive controls and to determine the optimal concentra-
tions for the primary antibody. For negative controls, the
primary antibodies were not added.
Histomorphometry and image processing. Histologi-
cal sections taken from 2 separate planes (100- to 500-mm
difference) of each scaffold were used for analyses. Low-
magnification (2objective) images of whole cross-sections
of tissue samples were acquired using a CCD camera (RT
Color 2.2.1, Diagnostic Instruments, Sterling Heights, MI)
mounted on an inverted microscope (E600, Eclipse, Nikon,
Melville, NY). RGB images were acquired using Spot, an
image-acquisition program (Diagnostic Instruments, Ster-
ling Heights, MI). The illumination of each picture was
controlled so that the exposure for each image was the
same; thus the brightness, contrast, and saturation of the
images were captured using the same parameters.
Image processing was performed on the RGB images
in Matlab (The Mathworks, Natick, MA) to determine the
ratio of positive Safranin O staining to the available pore
space and the average stain intensity of the section. The
prior calculation was correlated to the number of chon-
drocytic cells that have not dedifferentiated, whereas the
latter was correlated to the amount of sGAG present in the
ECM.25,26 Matlab code was written to convert the RGB
image (Fig. 3A) to hue saturation value (HSV) and thresh-
old out the scaffold and background so that only the areas
of positive Safranin O staining remained (Fig. 3B). The
pixel area was calculated for these extracted areas to de-
termine the area of positive Safranin O staining for the sec-
tion. The background was subtracted from the picture and
was thresholded again to remove the scaffold, but this time,
pore space that did not stain for Safranin O was selected
(Fig. 3C). The 2 extracted areas were combined to calculate
the total pore space that was available for that particular
section (Fig. 3D). Using these 2 areas, the percentage of
positive Safranin O staining for the section is calculated.
The second set of histomorphometric data assessed was
the overall intensity of the stain. The extracted areas of
positive Safranin O staining were used for this calculation.
The intensity (I) was calculated using the equation I¼
(RþGþB)/3.27 A value between 0 and 1 corresponding to
the overall density of stain was assigned for each pixel. The
image was divided into 5050 pixel blocks, and the av-
erage intensity of each block was calculated (Fig. 3E). The
values from each 5050 pixel block were used to deter-
mine the average intensity of the entire section. The histo-
morphometric data was statistically analyzed using ANOVA
to determine whether hydrogels containing HyA/collagen
I promoted more chondrogenesis than hydrogels with col-
lagen I alone. All statistical tests were performed using SPSS
(SPSS Inc., Chicago, IL).
RESULTS AND CONCLUSIONS
In vitro comparison of hydrogels
After up to 2 weeks in culture with basal or chondro-
genic medium, 97% to 99% of all cells in collagen I-only
hydrogels and HyA/collagen I composite hydrogels re-
mained viable. Additionally, the number of viable cells after
2 weeks in culture was greater than after 1 week in culture.
The number of cells increased with increasing concentra-
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tions of HyA and was also greater in hydrogels cultured in
chondrogenic medium than in basal medium. These results
verify that all combinations of medium and hydrogel stud-
ied are capable of supporting chondrocyte activity.
The addition of HyA to collagen I hydrogels generally
resulted in greater sGAG deposition than with hydrogels
with collagen I alone (controls), irrespective of the culture
medium or the culture duration (Fig. 4A). After 1 week in
basal culture medium, 1%, 2%, and 5% HyA/collagen hy-
drogels had significantly greater ( p< 0.05) sGAG/DNA
ratios than collagen I-only hydrogels; a 10% HyA/collagen
hydrogel had significantly less sGAG/DNA than the control.
Similarly, after 1 week in chondrogenic culture medium,
2%, 5%, and 10% HyA/collagen hydrogels had greater
sGAG/DNA ratios than collagen I-only hydrogels (only the
5% result was statistically significant); a 1% composite
hydrogel had slightly, but not significantly, less sGAG/DNA
than the control. Composite hydrogels cultured in chon-
drogenic medium had higher sGAG/DNA on average than
those cultured in basal medium although only significantly
for the 10% hydrogel. Collagen I-only hydrogels also had
significantly higher sGAG/DNA in chondrogenic medium.
After 2 weeks in culture, all composite hydrogels dis-
played greater sGAG deposition than controls (Fig. 4B). In
the basal medium, 1%, 2%, 5%, and 10% HyA/collagen
hydrogels had significantly greater ( p< 0.05) sGAG/DNA
ratios than collagen I-only hydrogels. In the chondro-
genic culture, only the 5% HyA/collagen hydrogels had
FIG. 3. Example of the histomorphometrical analysis used to quantify the amount of Safranin O staining. (A) RGB image acquired
from microscope with 2objective. (B) Areas of positive Safranin O staining extracted from RGB image. (C) Remaining areas of non-
positive staining extracted from RGB image. (D) Combined image of positive (B) and non-positive staining (C) representing the total
scaffold pore space. The ratio of positive Safranin O to total pore space is expressed as a percentage. For this particular specimen, the
ratio was 36%. (E) Calculation of stain intensity (I) using the equation, I¼ (RþGþB)/3. The average intensity of each block is cor-
related to the amount of sulfated glycosaminoglycan present in the block. Color images available online at www.liebertpub.com/ten.
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significantly greater sGAG/DNA ratios than collagen I-only
hydrogels. In contrast to the 1-week results, composite hy-
drogels cultured for 2 weeks in chondrogenic medium had
significantly lower sGAG/DNA on average than those cul-
tured in basal medium. However, sGAG/DNA for collagen
I-only hydrogels remained significantly higher in the chon-
drogenic medium. Comparison of the 1-week and 2-week
results showed that sGAG/DNA increased significantly for
all hydrogels (composite and controls) cultured in basal me-
dium and conversely decreased, although not significantly,
for hydrogels in the chondrogenic medium.
Of all combinations of hydrogel and medium, the highest
amount of matrix formation, as quantified according to the
amount of sGAG normalized by the amount of DNA, was
obtained with a 5% composite hydrogel cultured in basal
medium. This combination was thus chosen to seed chon-
drocytes into PPF scaffolds that subsequently were im-
planted into mice in in vivo experiments.
Fabricated scaffold properties
The micro-computed tomography scans of representative
fabricated PPF scaffolds are shown in Figure 2 (A3, B3).
The measured features of the fabricated scaffolds were
within 5% of the designed specifications. The porosities of
the fabricated scaffolds were 50% and 49% for the cubic
and ellipsoidal scaffolds, respectively. The effective per-
meability tensor, K, for the [x-axis, y-axis, z-axis] was cal-
culated for each scaffold design. For the cubic scaffold, the
calculated K was [2.16107, 2.16107, 2.16107 m3/
N*sec]. For the ellipsoid scaffold, the effective permeabil-
ity was [0.36107, 0.36107, 0.29107m3/N*sec].
The surface area:volume ratios were also calculated for each
unit cell using Solidview software (Solid Concepts, Va-
lencia, CA). The cubic pore had a surface area of 2.7mm2
and a volume of 0.12mm3. The surface area:volume ra-
tio was therefore 23mm1. For the ellipsoid unit cell, the
calculated values were 4.4mm2 for the surface area and
0.17mm3 for the volume. This corresponds to a surface
area:volume ratio of 26mm1. For reference, the analogous
spheroid unit cell with [0.7, 0.7, 0.7mm] dimensions would
have a surface area:volume ratio of 28mm1.
In vivo comparison of hydrogels
The PPF scaffolds were seeded with chondrocytes using
5% HyA/collagen or collagen I hydrogels and cultured for
2 weeks in vitro. All scaffolds were implanted, and the
mice survived surgery without complication. All mice lived
4 weeks without signs of abnormality. All scaffolds were
extracted, found intact, and processed for histological anal-
ysis.
Cell phenotype verification. Microscopic examination
of the tissue/scaffold sections showed widespread positive
Safranin O staining of the pore spaces, confirming the pres-
ence of sGAG and viable chondrocytes. Chondrocytes fil-
led the pore spaces of the scaffolds and were surrounded by
dense ECM, which stained positive with Safranin O. The
general morphology of the cells were round and chondro-
cytic in appearance, with established lacunae, even at the
center of the scaffolds (Fig. 5A4, B4).
Within these same sections, some areas counterstained
with fast green, indicating the presence of non-cartilaginous
matrix. Spindle-shaped fibroblast-like cells and endothelial
cells were found in these areas, which were primarily at the
edges of the scaffolds, and in scaffold pores where cells were
embedded in collagen I. Positive fast green staining was
more prevalent in scaffolds containing collagen I-only hy-
drogels and less so in scaffolds containing HyA hydrogels.
Immunohistochemistry verified the presence of collagen
II and collagen I in the ECM. The prior confirms the pres-
ence of chondrocytes and the latter the presence of fibro-
blasts and dedifferentiated chondrocytes. Areas of detected
collagen II correlated well with the areas of positive Saf-
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FIG. 4. Results from dimethyl-methylene blue analysis of com-
posite hyaluronic acid (HyA)/collagen and collagen I-only hydro-
gels cultured in basal medium (gray bars) and chondrogenic (black
bars) medium. One-week data (A) and 2-week data (B) are pre-
sented. Statistical analyses comparing groups showed significant
differences (indicated with *) between 5% HyA hydrogels cultured
in basal medium and all other conditions ( p< 0.05). The sulfated
glycosaminoglycan/deoxyribonucleic acid (sGAG/DNA) ratios of
5% HyA hydrogels cultured in chondrogenic medium were greater
than all other conditions, but only significantly greater than 1%
and 2% HyA and control hydrogels.
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FIG. 5. Representative micrographs of scaffolds seeded with collagen (A) and 5% hyaluronic acid (HyA)/collagen (B) hydrogels.
Sections are stained with Safranin O/fast green FCF. Residual poly(propylene fumarate)is visible in the sections (stars) and stained
dark pink because the negatively charged polymer attracts the cationic Safranin O dye. The bar represents 1mm for images A1
and B1. Results from histomorphometric analyses performed on sections A1 and B1 are shown in A2, A3 and B2, B3, respectively.
A2 is a representative section from scaffolds with collagen I hydrogel showing approximately 30% positive Safranin O staining, and
B2 is a representative section from scaffolds with 5% HyA/collagen hydrogel that has approximately 60% positive Safranin O
staining. The calculated intensities of the Safranin O staining for the sections are shown in A3 and B3. The average intensity or fixed
charge density of the sections is 14 and 25 per mm2 for A3 and B3, respectively. Higher magnifications of the areas within the
dashed boxes show round chondrocytic cells surrounded by positively stained extracellular matrix. The bar represents 125 mm for A4
and B4. Color images available online at www.liebertpub.com/ten.
CARTILAGE ENGINEERING USING HyA HYDROGELS AND PPF SCAFFOLDS 545
matrix (Fig. 6). Collagen I was detected in areas of non-
cartilaginous connective tissue and in some regions of weak
Safranin O staining, such as the edges of the scaffolds and
in pores with fibroblastic cells or where vascularization was
observed (Fig. 7).
Histomorphometric analysis. Positive staining was found
in all specimens, but more-robust and -intense staining was
seen in scaffolds with composite 5% HyA/collagen hydro-
gels than with collagen I-only hydrogels (Fig. 5). Histo-
morphometrical analysis of the Safranin O stained slides
confirmed these observations (Fig. 8A). The percentage of
pore area stained positive with Safranin O for scaffolds
seeded with composite 5% HyA hydrogels was 63 6% for
cubic geometries (n¼ 4) and 59 2% (n¼ 4) for ellipsoidal
geometries. The percentage of pore area stained positive
with Safranin O for scaffolds seeded with collagen I-only
hydrogels was 29 4% for cubic-pore geometries (n¼ 4)
and 32 5% (n¼ 4) for ellipsoidal-pore geometries. Sta-
tistical analysis showed that the chondrocytes cultured in
composite 5% HyA/collagen I hydrogels had significantly
greater areas of positive Safranin O staining. These results
indicate that more chondrocytes are present in the HyA
hydrogel than the collagen I hydrogel and lead to the con-
clusion that HyA promotes proteoglycan synthesis and has
a chondroprotective effect on chondrocytes, increasing phe-
notype stability at an ectopic site.
The average intensity of the Safranin O staining was also
higher in the HyA scaffolds than the collagen I scaffolds
(Fig. 8B). The average intensities per mm2 of pore space
for scaffolds with 5% HyA hydrogels were 25 2 for cubic-
pore geometries (n¼ 4) and 23 3 (n¼ 4) for ellipsoidal-
pore geometries. The average intensities per mm2 for the
scaffolds with collagen I hydrogels alone were 14 3
for cubic-pore geometries (n¼ 4) and 14 2 (n¼ 4) for
ellipsoidal-pore geometries. The intensity of the Safranin O
stain correlates directly to the amount of sGAG present
in the matrix.25 The results showed significantly greater
amounts of sGAG in the ECM of the scaffolds with 5%
HyA hydrogels.
Both scaffold pore designs were capable of supporting
cartilage tissue development, although a statistical differ-
ence was not found between designed cubic and ellipsoidal
scaffolds in the area of positive Safranin O staining or the
intensity of the stain.
DISCUSSION
The aim of this study was to evaluate the effects of com-
posite HyA/collagen I hydrogels on chondrocytes in vitro
and in vivo. Most clinical applications of HyA are admin-
istered as interarticular injections, with which the residence
time of the HyA is limited to days.28 The incorporation of
FIG. 6. Representative micrographs of immunohistochemistry detecting collagen II of scaffolds seeded with collagen I (A) and 5%
hyaluronic acid (HyA)/collagen I (B) hydrogels. Positive staining for collagen II was found in all scaffolds, but greater areas of positive
staining were seen in scaffolds seeded with 5% HyA/collagen I hydrogels. The areas of detected collagen II correlated well with areas of
positive Safranin O staining. The bar represents 0.5mm for images A1 and B1. Higher magnification of areas within dashed boxes
shows chondrocytic cellular morphology. The bar represents 125 mm for images A2 and B2. Color images available online at www
.liebertpub.com/ten.
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HyA into collagen I hydrogels may increase the lifetime
in vivo and extend the timeframe of its chondroprotective
properties.
At low concentrations, HyA modulates cell proliferation
and matrix synthesis. Our results are consistent with previ-
ous studies, in which increases in sGAG production and cell
proliferation were seen with the addition of HyA concen-
trations between 0.1 and 0.5mg/mL.11,29 At high concen-
trations, individual HyA domains overlap and may form
entanglements through self-association and steric interac-
tions.30,31 These steric interactions and hydrophobic patches
may deter proteins and other large molecules with large
hydrodynamic sizes from diffusing through the composite
HyA hydrogels. However, our results show that, at certain
concentrations of HyA (5% or 0.23mg/mL), it may be
possible to overcome this effect. At a favorable concentra-
tion of HyA, a larger number of cells is able to bind to HyA
that is in the environment to promote cell movement, pro-
liferation, aggregation, and degradation of HyA and mediate
the formation of pericellular matrices.32 Beyond this con-
centration, the aggregation effect is inhibited because of the
saturation of cell receptors for HyA.33
The culture medium is also a contributing factor in cel-
lular metabolism and matrix synthesis. Our results show that
the chondrogenic medium significantly increased sGAG/
DNA at both timepoints for hydrogels containing collagen I
and the 10% HyA hydrogel at 1 week, although mainly
small differences were seen between the other composite
HyA hydrogels cultured in basal and chondrogenic medium.
This difference may also be attributed to the steric inhibi-
tions and entanglements of the HyA molecules preventing
the proteins in the chondrogenic medium from diffusing
into the hydrogels. This indicates that the interactions of
HyA chains may be a candidate for influencing nutrient dif-
fusion. Furthermore, contrary to our expectations, a propor-
tionate increase in sGAG production did not accompany the
increase in cell proliferation seen with cells cultured in
chondrogenic medium. This may explain the decrease of the
sGAG/DNA ratio from week 1 to week 2, although, further
analysis of the gene expression and assessment of the colla-
gen production of these cells may help clarify these results.
Overall, our results show that the addition of HyA to
collagen I hydrogels creates an environment that may be
more conducive for chondrocyte proliferation and greater
ECM production. Chondrocytes are able to bind to HyA
through surface receptors such as CD44 and receptor
for hyaluronic acid mediated motility.34,35 The binding of
chondrocytes to HyA may not only increase cellular re-
tention within the hydrogels, but also reduce morphological
changes due to interactions with collagen I fibrils.5 The
presence of HyA may also increase the number of attach-
ment sites for chondroitin sulphate, keratan sulphate, and
other sGAGs. This increase in sGAG retention within the
hydrogel can be seen with the increase of sGAG measured
FIG. 7. Representative micrographs of immunohistochemistry detecting collagen I in scaffolds seeded with collagen I (A) and 5%
hyaluronic acid (HyA)/collagen I (B) hydrogels. Positive staining for collagen I was found in some pore spaces, mainly at the edges of
scaffolds, and was more prominent in scaffolds seeded with collagen I alone. The bar represents 0.5mm for images A1 and B1. Higher
magnifications of areas within dashed boxes are shown in A2 and B2. The bar represents 125 mm for A2 and B2. Color images available
online at www.liebertpub.com/ten.
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in the composite gels with the DMMB assay. The increase
in sGAG is also seen in vivo, where the area of positive
Safranin O staining and the intensity of the stain was sig-
nificantly higher than in the collagen I hydrogels. Further-
more, the increase of sGAG binding to HyA may enhance
the compressive properties of the hydrogel by recreating
the negative charge repulsions present in native cartilage.
In previous studies, various hydrogels, cross-linked ethy-
lic and benzylic esters of hyaluronan (Hyaff)36,37 and
polyglycolic acid37,38 were able to support chondrocyte at-
tachment and ECM formation. However, the mechanical
properties of these constructs must be assessed to determine
whether these scaffolds are able to support adequate loads.
The primary function of the PPF scaffold in this study was to
support the developing repair tissue and protect it from ex-
cessive external forces. Our results show that PPF is able to
support chondrocyte growth and matrix deposition. PPF is a
biodegradable polymer that will allow the regenerating tis-
sue to slowly replace the degrading biomaterial. It is bio-
compatible with minimal immunological reactions.23 In
the future, the mechanical properties of the designed PPF
scaffolds alone and with cells will need to be evaluated.
Ideally, the scaffold properties should match those of na-
tive cartilage. The mechanical properties of these scaffolds
can be easily adjusted by altering the ratio of PPF to
NVP, which changes the amount of cross-linking.39 Thus, the
properties of the scaffold and polymer degradation time can
be calibrated to match tissue regeneration.
An advantage of using SFF scaffolds over non-woven
meshes and scaffolds fabricated using particulate leaching
is that the user can define the pore architectures, pore sizes,
and overall scaffold porosity. We designed scaffolds with
pores that were cubic or ellipsoid in shape. Although the
results did not show a significant difference between these
scaffold designs, it is promising that, even with lower ef-
fective permeabilities, the tissue that developed in the el-
lipsoid pore was fairly robust and was comparable with the
tissue found in the cubic-pored scaffolds. The permeability
in this study may not be a large factor in ECM production
because the chondrocytes are able to alter their aerobic
pathways in favor of anaerobic metabolism easily. Chon-
drocytes are well adapted to conditions with low perme-
abilities and low oxygen tensions similar to those found
in vivo in the joint. Although we did not see a difference
between the ECM formation due to the scaffold designs,
some studies have shown that lower oxygen tensions help
support greater matrix production and lower dedifferenti-
ation.40 Furthermore, we believe that an increase in the
surface area: volume ratio due to pore geometry should
increase cellular attachment and growth and increase the
amount of ECM that is deposited in the scaffold pore space.
Perhaps a spheroidal-shaped pore or a different cell type
will help to further elucidate the differences between scaf-
fold pore geometries. It is possible that the cellular en-
capsulation in the hydrogels prevented attachment to the
polymer surface; therefore, the cellular density and com-
position of the hydrogels were the major factors in deter-
mining ECM deposition and cell proliferation.
In conclusion, a combination of composite HyA hydro-
gels and a custom-designed SFF scaffold may provide a
promising functional construct for cartilage repair. The ben-
eficial effects of HyA make it a good substrate for tissue-
engineering applications, but there are limits to this effect
depending on the concentration of HyA. At high concentra-
tions, the effects of steric inhibition, self-association, and
chain entanglement become important factors influencing
nutrient diffusion and cellular metabolism. The ability to
design scaffold properties such as porosity, permeability,
and shape using SFF will be important in the creation of a
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Collagen I 5% HyA/Collagen I
FIG. 8. Results from histomorphometric analyses of Safranin O
stained sections. Data from scaffolds with cubic pores are shown
in gray bars, and data from scaffolds with ellipsoidal pores are
shown in black. Significantly greater areas and densities were
found in scaffolds seeded with 5% hyalinuric acid (HyA) hydro-
gels. (A) The percentage of Safranin O staining is equivalent to
the area of positive Safranin O staining normalized by the avail-
able pore space. (B) The fixed-charge density is the average stain
intensity of the section, which is directly correlated to the amount
of sulfated glycosaminoglycan in the extracellular matrix. *Sig-
nificant difference ( p< 0.05) from scaffolds with collagen I-only
hydrogels.
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